Product Details
| Product Name:
SP-141 |
CAS No.:
1253491-42-7 |
| Purity:
99.21% |
Supply Ability:
10g |
| Release date:
2026/05/11 |
Product Introduction
Bioactivity
| Name | SP-141 |
| Description | SP 141 is a MDM2 inhibitor.SP-141 promotes MDM2 auto-ubiquitination and degradation, with anticancer activity. |
| In vitro | SP141, which bound directly to MDM2, promoting its auto-ubiquitination and degradation by the proteasome.?The compound reduced levels of MDM2 in pancreatic cancer cell lines, as well as their proliferation, with 50% inhibitory concentrations <0.5 μM (0.38-0.50 μM).?Increasing concentrations of SP141 induced increasing levels of apoptosis and G2-M-phase arrest of pancreatic cancer cell lines, whether or not they expressed functional P53[1]. |
| In vivo | Injection of nude mice with SP141 (40 mg/kg/d) inhibited growth of xenograft tumors (by 75% compared with control mice), and led to regression of orthotopic tumors[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 1 mg/mL (3.08 mM), Sonication is recommended.
DMSO : 4.4 mg/mL (13.56 mM), Sonication is recommended.
|
| Keywords | SP-141 | SP141 | pancreatic | MDM-2/p53 | Mdm2 | Inhibitor | inhibit | degradation | cancer | breast | auto-ubiquitination |
| Inhibitors Related | 10-Hydroxydecanoic Acid | Flubendazole | Diuron | Gallium maltolate | PRIMA-1 | XI-006 | Tebufenozide | D-(-)-3-Phosphoglyceric acid disodium | Thiabendazole | Triglycidyl isocyanurate | Methyl methanesulfonate | (E/Z)-10-Hydroxy-2-decenoic acid |
| Related Compound Libraries | Anti-Colorectal Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Bioactive Compound Library | Ubiquitination Compound Library | Anti-Cancer Metabolism Compound Library | Inhibitor Library | NO PAINS Compound Library | PPI Inhibitor Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$64.00
|
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-06-02 |
|
|
$1980.00
|
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-05-11 |
|
|
|
VIP1Y
|
Shanghai Yimeixin Technology Co., LTD
|
2026-06-22 |
United States